All Middle East & Africa articles – Page 2
-
NewsWhen a lip ulcer isn’t what it seems: Rare case of syphilis mistaken for mouth injury
Any lip ulcer that is painless, firm, and persists beyond two to three weeks should prompt syphilis testing, even if the presentation does not fit the typical genital picture, warn scientists presenting an unusual case study.
-
NewsWarm temperatures disrupt spider sex-changing bacteria in dwarf-spiders across generations
A new study reveals that exposing dwarf spiders to a brief period of warm temperatures can disrupt a phenomenon where internal bacteria normally force genetic males to develop as females.
-
NewsResearchers call for increased screening for parasitic disease linked to HIV and cervical cancer risk
New research has highlighted the need to test millions of women and girls for female genital schistosomiasis (FGS), a neglected disease that can increase the risk of chronic illness, HIV and cervical cancer.
-
ArticleCOVID-19 vaccine boosters may help protect against future animal coronaviruses
COVID-19 vaccine boosters not only protect against SARS‑CoV‑2 but may also help protect against some future coronaviruses that risk spreading from animals to humans, researchers have shown.
-
NewsAntibiotics reverse damage caused to blood stem cells by chronic Salmonella
A new study has revealed that long-term Salmonella infections severely damage blood stem cells - but this damage is completely reversible. Giving an effective course of antibiotics fully restores the stem cells, allowing them to recover their health and rebuilding power.
-
NewsMount Sinai scientists develop first fully human monoclonal antibody cocktail that protects against Nipah and Hendra viruses
New preclinical study demonstrates that a novel monoclonal antibody cocktail provides complete protection against lethal Nipah and Hendra virus infection.
-
NewsGlobal assessment of ocean warming impacts on marine ecosystems
New study reveals that year‑round ocean heating by 1.5°C drives over 200 documented marine ecosystem disruptions.
-
NewsSea anemone flips a human antiviral strategy on its head
A new study has uncovered a previously unknown antiviral defense mechanism in sea anemones, revealing that animals may have evolved more than one way to fight viral infections.
-
NewsHealthy infant microbiomes appear to protect against malaria
A small preliminary study shows that 6-week-old infants with healthy gut microbiomes are less likely to contract malaria in their first year of life, suggesting the intriguing possibility that treatments such as probiotics could be protective against malaria.
-
NewsVeterinary review warns antibiotic resistance threatens vision in pets
A new review warns sight-threatening antibiotic-resistant eye infections are becoming a significant threat to vision in dogs, cats, and horses with multidrug-resistant bacteria becoming more common in referral veterinary settings.
-
NewsHow sea-ice microbes survive the Southern Ocean’s harsh winter, and the implications for climate change
New study reinforces the importance of the Southern Ocean marginal ice zone as a critical hotspot for global sulfur cycling where biogeochemical processes for climate regulation are enhanced.
-
NewsScientists uncover hidden phosphorus reservoir vital for future food production
Researchers have developed a simpler and more cost-effective method to measure a biologically important form of phosphorus in soils, providing new insights into nutrient cycling that could help improve sustainable agricultural management.
-
NewsTropical ocean temperatures drive changes in malaria cases in Malawi
New research shows that temperatures in the tropical Atlantic and Indian Oceans drive year-to-year changes in malaria cases in Malawi.
-
NewsSugar-free diets may disrupt gut microbiome
Eliminating sugar from your diet may be more detrimental than previously thought, according to an animal study. Mice fed a sucrose-free diet developed impaired glucose control, insulin resistance, gut microbial imbalance, intestinal inflammation and fatty liver changes, despite having no significant differences in body weight compared with control mice.
-
NewsMicrobial research captured among winning science images
Microbial research features among some of the winning images in Nature’s 2026 Scientist at Work photography competition. Microbiome sampling of whale sharks, algal blooms, and a coral probiotics village feature among five spectacular images showcasing the diversity and challenges of scientific research.
-
NewsAll-new lab in Kenya fills critical gap in wildlife health
Conservation stakeholders gathered to celebrate the official opening of the Laboratory in Northern Kenya (LiNK), an all-new veterinary diagnostic lab designed to fill a critical need for accessible diagnostic infrastructure in the remote region.
-
NewsAccelerating chikungunya vaccine development in Africa: Launch of the ACT-CHIK Project
Funded by the Global Health EDCTP3 Joint Undertaking, a new €15.3 million project coordinated by Institut Pasteur brings together seven partners across four continents to advance clinical trials and prepare for the manufacturing of a chikungunya vaccine in Africa.
-
NewsIndigenous mushroom transforms agricultural waste into food
An edible, seasonal mushroom in Eastern Nigeria has nutritional and therapeutic potential but is poorly researched. New research suggests that domestication of Lentinus squarrosulus using waste materials, specifically sawdust, could boost food production and provide employment opportunities for farmers and small businesses.
-
News CEPI fast-tracks three Bundibugyo ebolavirus vaccine candidates
The Coalition for Epidemic Preparedness Innovations (CEPI) will urgently accelerate development of three investigational vaccines targeting the Bundibugyo ebolavirus that has caused a rapidly spreading epidemic in the Democratic Republic of the Congo (DRC) and neighbouring Uganda.
-
NewsPhase 1 clinical trial set to begin on first leishmaniasis vaccine
A phase 1 clinical trial testing the safety of a leishmaniasis vaccine is set to begin in the coming months. The live vaccine, found to be safe in animals, is expected to be tested in humans later this year.